Ascendis Pharma (NasdaqGS:ASND) FY Conference Transcript

Ascendis Pharma (NasdaqGS:ASND) FY Conference March 02, 2026 11:10 AM ET Company ParticipantsJan Møller Mikkelsen - President and CEOConference Call ParticipantsYaron Werber - Managing Director and Senior Biotechnology AnalystYaron WerberWell, welcome everybody to the 46th annual TD Cowen Healthcare Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate the literally virtual fireside chat with Ascendis on the heels of the YUVIWEL approval. We moved the participation to vir ...